Granules India received tentative USFDA approval for Amphetamine Extended-Release Orally Disintegrating Tablets, offering 180-day exclusivity.
Granules India stock gains on USFDA nod for ADHD drug
view original post
Granules India received tentative USFDA approval for Amphetamine Extended-Release Orally Disintegrating Tablets, offering 180-day exclusivity.